Integrate HTP Computational Biology & Machine Learning to Streamline Drug Discovery & Development, & Enhance Predictability & Decision Making

As large language models like ChatGPT create ripples across all industries, and machine learning and other computational approaches undergo rapid advancements, there’s a lot to be excited for their applications in biotherapeutics discovery and development.

Created by biopharma-for biopharma, the 8th Computational Drug Development (CDD) for Biologics Summit stands out as the only industry-led meeting dedicated to the industrial applications of computational biology for biologics discovery and development, with real-world case studies that will empower you to extrapolate data & leverage deep learning tools to progress your novel, complex biologics pipeline.

Returning to Boston in October 2023 to further this goal, the 8th Annual summit will gather the industry for an unparalleled learning and networking opportunity, which will enable you and your team to push the next AI-enabled biologic into the clinic in a safe, time-efficient and cost-effective way!

Your 25+ Speakers Include:

Huanyu Zhou

Senior Director, Head, AI Data Science

Teva Pharmaceuticals

Matt Martin

Matt Martin Global Head, Computational Safety Sciences

Pfizer

Michael Marlow

Director, Biologics, Chemistry, Manufacturing & Controls Research

Boehringer Ingelheim

Yu Qiu

Head, AI Innovation for Antibody

Sanofi

Bin Li

Director, Computational Biology

Takeda

Maria Wendt

Global Head, Digital & Biologics Strategy & Innovation, Large Molecule Research

Sanofi

Philip Kim

Professor

University of Toronto

Sunidhi Lenka

Postdoctoral Scientist

Genentech

2023 Expertise Partner:

schrodinger